Press Releases on February 26, 2025 - EIN Presswire - Press Release Distribution Service

Published on February 26, 2025 - 13:00 GMT

IN8bio to Present at the TD Cowen 45th Annual Health Care Conference

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell therapies, today announced that William Ho, CEO and co-founder, will be presenting at the …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 26, 2025 - 13:00 GMT

Aspargo Labs Appoints Mario Guralnik as Chief Regulatory Officer

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Aspargo Labs, Inc. (“Aspargo Labs” or the “Company”), a specialty pharmaceutical and MedTech company focused on converting the world’s most meaningful medications into liquid oral suspensions for delivery in …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2025 - 13:00 GMT

Credit Bureaus Market to Reach $385.6 Billion, Globally, by 2032 at 13.4% CAGR: Allied Market Research

Wilmington, Delaware, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Credit Bureaus Market by Product/Service (Credit Score, Credit Reports and Credit Check Services), Report Type (Corporate Report and Individual …

Distribution channels: Banking, Finance & Investment Industry, Book Publishing Industry ...

Published on February 26, 2025 - 13:00 GMT

Freshworks and Unisys Join Forces to Transform IT Service Management for Mid-Market and Enterprise Companies

SAN MATEO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Freshworks Inc. (NASDAQ: FRSH), a leader in people-first AI service software, today announced a strategic relationship with Unisys (NYSE: UIS), a leading global technology solutions provider, to resell …

Distribution channels: Companies ...

Published on February 26, 2025 - 13:00 GMT

iAnthus Expands Presence in Florida with New GrowHealthy Dispensary in Jacksonville

NEW YORK and TORONTO, Feb. 26, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCQB: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, has announced the …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on February 26, 2025 - 13:00 GMT

Septerna to Present at TD Cowen 45th Annual Health Care Conference

SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that Jeffrey Finer, M.D., Ph.D., Chief Executive …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2025 - 13:00 GMT

Intermex Reports Fourth-Quarter and Full-Year Results

Company delivers ~10% EPS growth in 2024 Company to Host Conference Call Today at 9 a.m. ET MIAMI, Feb. 26, 2025 (GLOBE NEWSWIRE) -- International Money Express, Inc. (NASDAQ: IMXI) (“Intermex” or the “Company”), one of the nation’s leading omnichannel …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on February 26, 2025 - 13:00 GMT

KALA BIO to Present at TD Cowen 45th Annual Health Care Conference

ARLINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, today …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on February 26, 2025 - 13:00 GMT

NewAmsterdam Pharma Reports Full Year 2024 Financial Results and Provides Corporate Update

-- EMA submission expected in 2H25 by partner Menarini -- -- Additional data from BROADWAY, BROOKLYN, and TANDEM to be presented throughout 2025 -- -- Phase 3 PREVAIL CVOT remains on track -- -- $834.2 million in cash, cash equivalents and marketable …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2025 - 13:00 GMT

CG Oncology to Present at the TD Cowen 45th Annual Health Care Conference

IRVINE, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2025 - 13:00 GMT

Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update

High dose and low dose of TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in all pediatric, adolescent and adult patients treated (high dose, n=6; low dose, n=4) across both REVEAL trials as of February 2025 data …

Distribution channels: Business & Economy, Technology ...

Published on February 26, 2025 - 13:00 GMT

Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis ...

– Phase 1a study will evaluate single and multiple ascending doses of ABI-6250 in healthy participants with data expected in Q3 2025 – – Biomarker of ABI-6250 target engagement, serum bile acids, will be assessed in addition to safety and pharmacokinetic …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2025 - 13:00 GMT

Pacira BioSciences to Participate in Fireside Chat at Two Healthcare Conferences in March

PARSIPPANY, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 26, 2025 - 13:00 GMT

Protara Therapeutics to Present at the TD Cowen 45th Annual Health Care Conference

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2025 - 13:00 GMT

Disc Medicine to Participate in Upcoming Investor Conferences

WATERTOWN, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on February 26, 2025 - 13:00 GMT

4M Carbon Fiber and Carboscreen Announce AI-Powered Collaboration to Enhance Carbon Fiber Manufacturing

KNOXVILLE, Tenn., Feb. 26, 2025 (GLOBE NEWSWIRE) -- 4M Carbon Fiber, a pioneer in advanced carbon fiber manufacturing, has executed a Letter of Intent (LOI) with Carboscreen GmbH, a leader in artificial intelligence-driven fiber monitoring systems. This …

Distribution channels: Banking, Finance & Investment Industry, Companies ...

Published on February 26, 2025 - 13:00 GMT

Crescent Biopharma to Present at the TD Cowen 45th Annual Health Care Conference

WALTHAM, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent”), a private biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients with solid tumors, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on February 26, 2025 - 13:00 GMT

ABM to Announce First Quarter 2025 Financial Results

NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- ABM (NYSE: ABM), a leading provider of facility solutions, today announced that it will release its financial results for the Company’s fiscal first quarter 2025 on Wednesday, March 12, 2025, before market open. …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on February 26, 2025 - 13:00 GMT

Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs

FDA Fast Track Designation granted for Phentolamine Ophthalmic Solution 0.75% as treatment of significant chronic night driving impairment in keratorefractive patients with reduced mesopic vision Enrollment completion in LYNX-2 pivotal Phase 3 trial …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...

Published on February 26, 2025 - 13:00 GMT

PDS Biotech Announces Positive Clinical Data Demonstrating Compelling Survival and Clinical Responses in Recurrent/Metastatic HPV-...

Median Overall Survival (mOS) of 42.4 months in immune checkpoint inhibitor naïve patients; Historical published result is 7-12 months Continued survival in the cohort of HPV16-positive immune checkpoint inhibitor naïve patients - mOS not yet reached …

Distribution channels: Healthcare & Pharmaceuticals Industry ...